Cover Image

Immunotherapy with HDC/IL-2 may be clinically efficacious in acute myeloid leukemia of normal karyotype

Immunotherapy with histamine dihydrochloride and low-dose interleukin-2 (HDC/IL-2) reduces the risk of relapse in the post-chemotherapy phase of acute myeloid leukemia (AML). Here we report the results of exploratory analyses of the clinical efficacy of HDC/IL-2 in AML with focus on the impact of ka...

Full description

Saved in:
Bibliographic Details
Main Authors: Malin S. Nilsson (Author), Alexander Hallner (Author), Mats Brune (Author), Staffan Nilsson (Author), Fredrik B. Thorén (Author), Anna Martner (Author), Kristoffer Hellstrand (Author)
Format: Book
Published: Taylor & Francis Group, 2020-01-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items